We describe a 27-year-old man with hypereosinophilc syndrome (HES) 
Introduction
The hypereosinophilic syndrome (HES) comprises heterogeneous hematologic disorders characterized by unexplained sustained eosinophilia (>1,500 eosinophils/μl for more than 6 months), which is associated with signs and symptoms of organ involvement (1, 2) .
Quite recently, approximately 50% of the cases of HES were reported to be caused by a cryptic deletion on chromosome 4q12, resulting in the generation of FIP1L1-PDGFRA fusion gene (3) (4) (5) (6) . FIP1L1-PDGFRα is a constitutively activated tyrosine kinase that provides proliferative and survival signals, and that can be inhibited by the small molecule kinase inhibitor imatinib (3, 6 (3, 5, (7) (8) (9) Fig. 2A and B) . Pathology of the resected specimen demonstrated numerous inflammatory cells including neutrophils and eosinophils infiltrated into the Tunica intima of the arteries with thrombosis without granuloma formation (Fig. 2C) (1, 2) .
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Recent reports (3, 5) (3, 6, 9) (2) . The possibility of Churg-Strauss syndrome could be finally excluded by the lack of a history of asthma, the absence of the extravascular granuloma formation in histopathology, and the negative result of p-ANCA (9, 16 (19, 20 (22) .
document the efficacy of imatinib mesylate (low dose such as 100 mg/day) in a majority of HES patients (65%). The discovery of the novel FIP1L1-PDGFRA fusion gene, which is a gain-of-function gene on chromosome 4q12, elucidated the theoretical background of the effectiveness of imatinib mesylate in HES patients

. Consequently, the detection of FIP1L1-PDGFRA fusion gene is useful for distinguishing patients with myeloproliferative variant of HES from those with idiopathic HES. The present patient is categorized as idiopathic HES, because neither FIP1L1-PDGFRA fusion gene nor T-cell receptor gamma gene rearrangement was detected. The occur-
F i g u r e 2 . ( A) E me r g e n c y l a p a r o t o my o f t h e p a t i e n t d e mo n s t r a t e d b r o a d a r e a o f p e r f o r a t i o n o f t h e s ma l l i n t e s t i n e . ( B ) B y d i r e c t v i s i o n , t h r o mb i c l o g g e d t h e b r a n c h e s o f me s e n t e r i c a r t e r y a s i n d ic a t e d b y a r r o ws . ( C) Hi g h ma g n i f i c a t i o n v i e w o f t h e i n n e r t a b l e o f t h e me s e n t e r i c a r t e r y ( He ma t o x y l i n -E o s i n s t a i n , × 2 0 0 o r i g i n a l ma g n i f i c a t i o n ) . T h e t h r o mb u s i s p r e s e n t i n t h e u p p e r l e f t s i d e o f t h e p i c t u r e . T h e r e a r e i n f i l t r a t i o n s o f t h e e o s i n o p h i l s ( a s i n d i c a t e d b y a r r o ws ) i n T u n i c a i nt i ma , s o me o f wh i c h a r e b r e a k i n g t h r o u g h E l a s t i c a i n t e r n a i n t o T u n i c a me d i a ( ＊ ) . Ho we v e r , t h e r e s t o f T u n i c a me d i a i s a l mo s t f r e e o f i n f l a mma t i o n ( n o t s h o wn ) .
rence of acute vascular thrombosis of mesenteric artery could not be prevented despite anti-coagulant therapy (12). There have been two reports on arterial disease similar to this patient. One is a report of the development of thromboangitis obliterans requiring amputation of the legs in a 47-year-old man with HES (13), and the other is a report of the development of brachial artery occlusion requiring brachialto-brachial bypass surgery in a 28-year-old woman with HES (14). However, vascular thrombosis of the mesenteric artery has never been reported among patients with HES in the literature (15). Published gastrointestinal manifestations of HES include ascites, diarrhea, gastritis, colitis, pancreatitis, cholangitis and hepatitis, but not intestinal perforation
In conclusion, it is important to recognize the possibility of acute thrombosis of the mesenteric artery as the cause of acute abdomen seen among patients with hypereosinophilia.
